Press Release
June 24, 2019
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
More
June 19, 2019
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
More
June 14, 2019
Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
More
May 31, 2019
Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
More
May 10, 2019
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
More
May 9, 2019
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
More
May 6, 2019
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019
More
March 19, 2019
Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial
More
March 12, 2019
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018
More
March 7, 2019